Blue Horseshoe Stocks: TLRY Recap & More


Tilray, Inc. TLRY

Our first order of business this morning is to just provide a quick recap of our successful options idea from Friday, which we did not provide yesterday due to the release of our Special Report on PASO.(Check that report out if you missed it)

In Friday’s newsletter, we submitted the TLRY Weekly $92.50-95 Calls as potential day-trade candidates, and every single contract in that range provided huge multi-bag gain opportunities!

$92.50 Calls – Range: 2.10-8.30 – Max Gain: 295%
$93 Calls – Range: 2.00-9.20 – Max Gain: 360%
$93.50 Calls – Range: 1.80-5.00 – Max Gain: 178%
$94 Calls – Range: 2.14-9.83 – Max Gain: 359%
$95 Calls – Range: 1.21-8.85 – Max Gain: 631%


OPKO Health, Inc. OPK – Review

The last time we signaled OPK for observation was just a few weeks ago, on December 28th, just as the stock was gapping up off of its annual lows. Following that report, we’ve seen a couple weeks of steady gains, in an overall range from 2.84-3.935. That represents a solid 39% increase, and a good start to the 2019 calendar year.

We’ve also observed CEO Phillip Frost purchasing 15,000 shares out of the open market yesterday, near those highs. The next step for OPK would be to make a run at its 200DMA of 4.12, so we’ll continue to keep it on our radar in the days and weeks ahead.


Extended Watchlist:
PASO, DTEA, FTNW, KTOV, CVM

Blue Horseshoe Stocks: SPY, TSLA Options

SPDR S&P500 ETF (SPY) – Options Ideas

We’ve now had two consecutive sessions of gains for stocks following a weeks-long downtrend, and are eager to see if this reversal of fortune has a more lasting effect. With a high degree of uncertainty at play, and the potential for volatile swings in either direction, we’re going to signal two opposing sets of ideas in the SPY chain, to set ourselves up for any eventuality. We may even see a case of another dip-and-rip kind of session, where we play one set early on and another later in the day.

Our two sets of ideas are going to be the SPY Weekly $248-249.50 Calls*, and the SPY Weekly $251-250 Puts*.  If the SPY can get above the premarket high of 251.16 during the session, we’ll look to our bullish ideas. Failure to do so, will cause us to track the bearish ones. Either way we should have good opportunities laid before us by the SPY today.


Tesla, Inc. TSLA – Options Idea

We’ve also formulated an idea for the TSLA chain. Tesla stock is getting another boost this morning after proposed additions to the board of directors, including Larry Ellison, the founder of Oracle Corp. (ORCL), are being very well received by investors.

We’re going to track the TSLA Weekly $322.50-327.50 Calls* on the heels of this announcement.
_____

*NEVER trade options with a weekly expiration on a Friday unless you are an advanced level trader with disposable funds!


Extended Watchlist:
QTM, TRVN, BHF, SFET, HSGX, BPMX, OPK, NMFC

Blue Horseshoe Stocks: BABA Options & More

Alibaba Group Holding Ltd BABA – Options

To kick off this brand new trading week, we are interested in tracking a range of calls in the BABA chain, after shares dipped on the news that co-Founder Jack Ma will be stepping down and handing full control over to the CEO effect next year.

The reactionary selloff may provide us with some solid options trading chances, so we are going to keep an eye on the BABA 10/12 $165 & 167.50 Calls in the days and weeks ahead.


OPKO Health Inc. OPK

Shares of OPK took a bath on Friday, briefly falling below the stock’s 200DMA, and closing well in the red on the day. We’re going to signal our interest in tracking OPK as a bottom-watch play.

The stock is approaching extremely oversold territory, and in the midst of its downturn we observed some Form-4 submissions, with insiders buying up shares on Friday as the bottom fell out.

That suggests a confidence that it may not have much further to fall, so we will want to hang around as OPK searches for a bottom and solid rebound point.



Extended Watchlist:
TAHO, ECYT, TLRY, CGC, AKER, CLDR, FRED, IGC

Blue Horseshoe Stocks: OPK, CAT & More

Opko Health, Inc. OPK

We’re going to start things off this morning by highlighting a potential bottom-bounce play in OPK which is presently boasting a ripening chart setup.

Not only that, but we’ve got a Form-4 alert on this one as well, with CEO Phillip Frost purchasing 100,000 shares yesterday at 4.89. We generally take insider buying at a bottom, especially a strong double bottom like OPK is exhibiting, as a sign that a more sustained recovery could be on the way.

We’ll place this stock on watch in the days and weeks ahead as well as keep an eye on an options idea, the OPK 03/02 $5-6 Calls.


Caterpillar Inc. CAT

Speaking of options ideas, we wanted to submit one for CAT as well in the wake of its premarket earnings release, wherein the company reported a 35% sales increase and a solid beat on profits.

The stock is gapping up into blue skies this morning in the $175 range, so we’ll be looking for a classic early dip-and-rip, and tracking the CAT Weekly $170-175 Calls for potential quick-strike trades.


Extended Watchlist:
RMGN, ATOS, CLF, MYSZ, GALT MDZ, LODE

Blue Horseshoe Stocks: WFM Followup, ZSAN & More

Whole Foods Market, Inc. WFM – Options Update

Our primary focus for yesterday morning’s premarket report was our running options idea from last week. We were mentioning that the WFM 02/17 $30 and 30.50 Calls had begun to heat up, and we didn’t want to miss out on the activity that seemed ready to kick our idea into effect.

Our assumptions turned out to be accurate, with WFM stringing on another good session performance. The $30 Calls traded up from a low of .54 to .90 (+66%), while the $30.50′s made their way from .20-.42 (+110%).

We also mentioned that a break of the 50DMA at 30.76 for WFM would prompt us to look at contracts with a higher strike price and later expiration, the WFM 02/24 $31 Calls. We did indeed witness a breach of that price point toward the end of the session, and those calls came into play as well, running from 20-.35 for a chance at a nice 75% gain.

Should the solid uptrend WFM has been putting together continue into future sessions, these could be an ongoing item of interest for us.


Zosano Pharma Corp. ZSAN

ZSAN is a play we highlighted on Monday after the company reported that in its ZOTRIP pivotal efficacy study, its M207 transdermal migraine therapy patch met both primary, as well as secondary endpoints.

We mentioned that not only were we going to experience the effect of positive study data, but a technically ripening chart as well, leading us to put the stock on high alert in coming sessions.

It was a good decision, as the stock has really gained momentum this week, putting together some solid sessions. In fact, yesterday the stock closed as the NASDAQ’s top gainer of the day. We’ve watched as ZSAN has traded up from a low of 1.65 to yesterday’s new high of 3.49, representing an intraweek upswing of 112% Cheers to those of our readers who came along for the ride!



Opko Health, Inc. OPK

We put OPK on bottom watch earlier this month, and after a few sessions of further consolidation, the past four trading days have shown some convincing bottom-bounce action.

The stock ultimately found support at the 7.99-level last week, from which it has logged five straight sessions of higher highs and higher lows, reaching 8.66 yesterday. While that action only equates to an 8% increase, it’s the massive gap on the chart to the upside from just under $10 to just over $11.50. We’ll look for the stock to continue to build gradually and maintain the current trend in hopes of seeing a run toward a gap-fill.


FRESH OPTIONS IDEA:

Kate Spade & Co. KATE Weekly $20 and $21 Calls


Extended Watchlist:
RSII, MAXD, SRMX, CLSN, TPX

Incoming search terms:

  • wfm 02